Farallon Capital Management’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,170,000
| Closed | -$6.91M | – | 170 |
|
|
2024
Q3 | $6.91M | Hold |
3,170,000
| – | – | 0.03% | 84 |
|
|
2024
Q2 | $7.32M | Hold |
3,170,000
| – | – | 0.03% | 80 |
|
|
2024
Q1 | $17.4M | Buy |
+3,170,000
| New | +$17.4M | 0.07% | 75 |
|
|
2022
Q4 | – | Sell |
-70,000
| Closed | -$2.44M | – | 253 |
|
|
2022
Q3 | $2.44M | Sell |
70,000
-860,648
| -92% | -$30M | 0.01% | 203 |
|
|
2022
Q2 | $11.4M | Sell |
930,648
-183,632
| -16% | -$2.25M | 0.06% | 127 |
|
|
2022
Q1 | $15.1M | Hold |
1,114,280
| – | – | 0.07% | 112 |
|
|
2021
Q4 | $22.1M | Buy |
+1,114,280
| New | +$22.1M | 0.11% | 89 |
|